535 related articles for article (PubMed ID: 23454684)
21. Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.
Kelly JT; De Colibus L; Elliott L; Fry EE; Stuart DI; Rowlands DJ; Stonehouse NJ
Antiviral Res; 2015 Dec; 124():77-82. PubMed ID: 26522770
[TBL] [Abstract][Full Text] [Related]
22. Co-circulation and genomic recombination of coxsackievirus A16 and enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central China.
Liu W; Wu S; Xiong Y; Li T; Wen Z; Yan M; Qin K; Liu Y; Wu J
PLoS One; 2014; 9(4):e96051. PubMed ID: 24776922
[TBL] [Abstract][Full Text] [Related]
23. Anti-enterovirus 71 activity screening of chinese herbs with anti-infection and inflammation activities.
Lin TY; Liu YC; Jheng JR; Tsai HP; Jan JT; Wong WR; Horng JT
Am J Chin Med; 2009; 37(1):143-58. PubMed ID: 19222118
[TBL] [Abstract][Full Text] [Related]
24. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening.
Xu L; Su W; Jin J; Chen J; Li X; Zhang X; Sun M; Sun S; Fan P; An D; Zhang H; Zhang X; Kong W; Ma T; Jiang C
Viruses; 2014 Jul; 6(7):2778-95. PubMed ID: 25036464
[TBL] [Abstract][Full Text] [Related]
25. Pyrrolidine dithiocarbamate inhibits enterovirus 71 replication by down-regulating ubiquitin-proteasome system.
Lin L; Qin Y; Wu H; Chen Y; Wu S; Si X; Wang H; Wang T; Zhong X; Zhai X; Tong L; Pan B; Zhang F; Zhong Z; Wang Y; Zhao W
Virus Res; 2015 Jan; 195():207-16. PubMed ID: 25456405
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity studies of bivalent inactivated virions of EV71/CVA16 formulated with submicron emulsion systems.
Lin CW; Liu CC; Lu TC; Liu SJ; Chow YH; Chong P; Huang MH
Biomed Res Int; 2014; 2014():670506. PubMed ID: 25006583
[TBL] [Abstract][Full Text] [Related]
29. Apigenin inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway.
Lv X; Qiu M; Chen D; Zheng N; Jin Y; Wu Z
Antiviral Res; 2014 Sep; 109():30-41. PubMed ID: 24971492
[TBL] [Abstract][Full Text] [Related]
30. Rheum emodin inhibits enterovirus 71 viral replication and affects the host cell cycle environment.
Zhong T; Zhang LY; Wang ZY; Wang Y; Song FM; Zhang YH; Yu JH
Acta Pharmacol Sin; 2017 Mar; 38(3):392-401. PubMed ID: 27840410
[TBL] [Abstract][Full Text] [Related]
31. Improved detection limit in rapid detection of human enterovirus 71 and coxsackievirus A16 by a novel reverse transcription-isothermal multiple-self-matching-initiated amplification assay.
Ding X; Nie K; Shi L; Zhang Y; Guan L; Zhang D; Qi S; Ma X
J Clin Microbiol; 2014 Jun; 52(6):1862-70. PubMed ID: 24648558
[TBL] [Abstract][Full Text] [Related]
32. Saururus chinensis (Lour.) Baill blocks enterovirus 71 infection by hijacking MEK1-ERK signaling pathway.
Wang C; Wang P; Chen X; Wang W; Jin Y
Antiviral Res; 2015 Jul; 119():47-56. PubMed ID: 25912818
[TBL] [Abstract][Full Text] [Related]
33. Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species.
Adianti M; Aoki C; Komoto M; Deng L; Shoji I; Wahyuni TS; Lusida MI; Soetjipto ; Fuchino H; Kawahara N; Hotta H
Microbiol Immunol; 2014 Mar; 58(3):180-7. PubMed ID: 24397541
[TBL] [Abstract][Full Text] [Related]
34. A laboratory evaluation of medicinal herbs used in china for the treatment of hand, foot, and mouth disease.
Chen X; Wang C; Xu L; Chen X; Wang W; Yang G; Tan RX; Li E; Jin Y
Evid Based Complement Alternat Med; 2013; 2013():504563. PubMed ID: 23554831
[TBL] [Abstract][Full Text] [Related]
35. Etiology of Multiple Non-EV71 and Non-CVA16 Enteroviruses Associated with Hand, Foot and Mouth Disease in Jinan, China, 2009-June 2013.
Guan H; Wang J; Wang C; Yang M; Liu L; Yang G; Ma X
PLoS One; 2015; 10(11):e0142733. PubMed ID: 26562154
[TBL] [Abstract][Full Text] [Related]
36. Understanding the epidemiological characteristics of EV71 and CVA16 infection to aid the diagnosis and treatment of hand, foot, and mouth disease.
Wang B; Li J; Wang Y; Du N; Sun L; Xiao H; Zhao Y; Bao W; Zhang W
J Med Virol; 2019 Feb; 91(2):201-207. PubMed ID: 30118553
[TBL] [Abstract][Full Text] [Related]
37. Replication kinetics of coxsackievirus A16 in human rhabdomyosarcoma cells.
Jin J; Han M; Xu L; An D; Kong W; Jiang C
Virol Sin; 2012 Aug; 27(4):221-7. PubMed ID: 22899429
[TBL] [Abstract][Full Text] [Related]
38. 4-Iminooxazolidin-2-One as a Bioisostere of Cyanohydrin Suppresses EV71 Proliferation by Targeting 3C
Xu B; Liu M; Ma S; Ma Y; Liu S; Shang L; Zhu C; Ye S; Wang Y
Microbiol Spectr; 2021 Dec; 9(3):e0102521. PubMed ID: 34787443
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of enterovirus 71 infection by polysaccharides extracted from Picochlorum sp. 122 via the AKT and ATM/ATR signaling pathways.
Guo M; Zheng R; Wu HL; Chen D; Su J; Xu T; Wu H; Xiang W; Li Y; Zhu B
Arch Virol; 2021 Dec; 166(12):3269-3274. PubMed ID: 34536128
[TBL] [Abstract][Full Text] [Related]
40. Immunological and biochemical characterization of coxsackie virus A16 viral particles.
Chong P; Guo MS; Lin FH; Hsiao KN; Weng SY; Chou AH; Wang JR; Hsieh SY; Su IJ; Liu CC
PLoS One; 2012; 7(11):e49973. PubMed ID: 23226233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
